相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?
Mina F. Nordness et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients
Manon Launay et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature
Vivek Kumar et al.
ONCOLOGIST (2020)
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
Noha Abdel-Wahab et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
Daan P. Hurkmans et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Checkpoint Inhibitor-Induced Rejection of a Liver Allograft: A Combination of Acute T Cell-Mediated and Antibody-Mediated Rejection
Brian T. Lee et al.
LIVER TRANSPLANTATION (2019)
Cardiovascular Toxicities Associated With Ibrutinib
Joe-Elie Salem et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Concomitant use of nivolumab and immunosuppressants in a renal transplant patient
H. Pluchart et al.
REVUE DES MALADIES RESPIRATOIRES (2019)
Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
Khashayar Esfahani et al.
NATURE COMMUNICATIONS (2019)
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue
Luis E. Aguirre et al.
ONCOLOGIST (2019)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti-CD154-Treated Monkeys
Tianshu Zhang et al.
TRANSPLANTATION (2018)
Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types
Caroline P. Perez et al.
TRANSPLANTATION (2018)
Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients
Ouidad Zehou et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin - case report
Jonathan W. Goldman et al.
BMC NEPHROLOGY (2018)
Rejet de greffe rénale induit par un anti-PD1
M. Reverte et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2018)
Immune Checkpoint Inhibitor Toxicity in 2018
Douglas B. Johnson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research
Dimitri Gassmann et al.
TRANSPLANTATION DIRECT (2018)
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience
Thomas T. DeLeon et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma
Brian D. Friend et al.
PEDIATRIC BLOOD & CANCER (2017)
Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient
Clement Deltombe et al.
TRANSPLANTATION (2017)
Acute liver graft rejection after ipilimumab therapy
S. Dueland et al.
ANNALS OF ONCOLOGY (2017)
Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients
Josh Levitsky et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy
C. L. Boils et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection
T. Alhamad et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma
L. Spain et al.
ANNALS OF ONCOLOGY (2016)
Corneal graft rejection in a patient treated with nivolumab for primary lung cancer
S. Le Fournis et al.
LUNG CANCER (2016)
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1
Evan J. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Renal Allograft Failure After Ipilimumab Therapy for Metastatic Melanoma: A Case Report and Review of the Literature
A. Jose et al.
TRANSPLANTATION PROCEEDINGS (2016)
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
Michael Ong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study
G. B. Klintmalm et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Role of the PD-1 Pathway in the Immune Response
L. V. Riella et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
Eric A. Engels et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
分享论文
